Promising results for nivolumab in advanced liver cancer
Promising results for nivolumab in advanced liver cancer
Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial
Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer
PARP inhibitor combo shows early promise for patients with and without BRCA mutations
Incidences of liver cancer rising in the USA
New approaches and new partnership models for biomarker based clinical research
Aims and successes of the 2nd EurocanPlatform project translational research course
Epigenome deregulation in cancer
Immunotherapy of cancer: recent progress and future challenges
Reasons to attend the EurocanPlatform translational research course 2015
2nd EurocanPlatform translational research course is good for networking
Biobanking biological materials and linkage to clinical information